Search results for " Left"

showing 10 items of 417 documents

Left ventricular function analyzed by Doppler and echocardiographic methods in short-term hypothyroidism

1995

Abstract In conclusion, a significant reversible decrease in contractility and an impaired diastolic relaxation was demonstrated in patients with short-term hypothyroidism. This must be considered in patients with preexisting heart disease.

AdultMalemedicine.medical_specialtyHeart diseaseDiastoleVentricular Function LeftContractilitysymbols.namesakeHypothyroidismInternal medicinemedicineHumansIn patientSystoleVentricular functionbusiness.industryMiddle Agedmedicine.diseaseEchocardiography DopplerThyroxinesymbolsCardiologyFemaleCardiology and Cardiovascular MedicinebusinessDoppler effectThe American Journal of Cardiology
researchProduct

Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

2007

Aims Anderson–Fabry disease (AFD) is an uncommon X-linked disorder caused by deficient activity of the lysosomal enzyme α-galactosidase A. The Fabry Outcome Survey is a European database designed to monitor the long-term efficacy and safety of enzyme replacement therapy (ERT) with agalsidase alfa. The aim of this study was to determine the prevalence and characteristics of cardiac disease in AFD patients. Methods and results Clinical and laboratory data were available in 714 patients from 11 countries (mean age 35 ± 17 years, 369 women, 336 treated). The prevalence of angina was 23 vs. 22%; palpitations and arrhythmias 27 vs. 26%; exertional dyspnoea 23 vs. 23%; and syncope 2 vs. 4%, in wom…

AdultMalemedicine.medical_specialtyHeart diseaseHeart DiseasesCardiomyopathyLeft ventricular hypertrophySyncopeAnginaRisk FactorsInternal medicinemedicinePalpitationsPrevalenceHumansVascular diseasebusiness.industryEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry diseaseRecombinant ProteinsSurgeryEuropeIsoenzymesDyspneaTreatment OutcomeEchocardiographyalpha-GalactosidaseFabry DiseaseFemaleHypertrophy Left Ventricularmedicine.symptomCardiology and Cardiovascular MedicinebusinessGlomerular Filtration RateEuropean heart journal
researchProduct

Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH.

2001

Left ventricular hypertrophy (LVH) in hypertensive subjects is associated with an increased prevalence of ventricular arrhythmias. To evaluate the effect of antihypertensive treatment on cardiac arrhythmias (CA) and transient episodes of myocardial ischemia (TEMI), we studied 46 hypertensive patients with LVH, divided into four groups randomly treated with enalapril, hydrochlorothiazide (HCTZ), atenolol, or verapamil (SR-V) for 6 months. Office blood pressure and office heart rate values were recorded, in basal conditions, after 1 and 6 months of treatment, and all patients underwent echocardiography, electrocardiographic Holter monitoring, and stress testing. All drugs significantly lowere…

AdultMalemedicine.medical_specialtyHeart diseaseMyocardial IschemiaBlood PressureLeft ventricular hypertrophyHydrochlorothiazideEnalaprilInternal medicineHeart rateInternal MedicinemedicineHumanscardiovascular diseasesEnalaprilAntihypertensive AgentsAgedmedicine.diagnostic_testbusiness.industryArrhythmias CardiacMiddle Agedmedicine.diseaseAtenololBlood pressureHydrochlorothiazideTreatment OutcomeAtenololVerapamilHypertensioncardiovascular systemCardiologyElectrocardiography AmbulatoryFemaleHypertrophy Left VentricularbusinessElectrocardiographyAnti-Arrhythmia Agentsmedicine.drugAmerican journal of hypertension
researchProduct

The effect of radiofrequency catheter ablation of frequent premature ventricular complexes and arrhythmia burden on left ventricular function

2016

Background: Frequent premature ventricular complexes (PVC) are related to reversible tachycardia-induced cardiomyopathy. However, the role of arrhythmia burden on the outcome of the catheter ablation has not been fully recognised. Aim: The aim of this study was to assess the effect of catheter ablation and PVC burden in patients with and without structural heart disease (SHD) on left ventricular ejection fraction (LVEF). Methods: Transthoracic echocardiography was done before and six months after radiofrequency catheter ablation in 109 consecutive patients (61 men, age 55 ± 17 years) with frequent PVCs. Sixty-five (59.6%) patients had underlying SHD. Results: The catheter ablation procedure…

AdultMalemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentCardiomyopathyCatheter ablation030204 cardiovascular system & hematologyVentricular Dysfunction Left03 medical and health sciencesQRS complex0302 clinical medicineInternal medicinemedicineHumanscardiovascular diseases030212 general & internal medicineventricular arrhythmiaAgedEjection fractionbusiness.industryleft ventricular ejection fractionStroke VolumeStroke volumeMiddle Agedmedicine.diseaseAblationstructural heart diseaseVentricular Premature ComplexesTreatment OutcomeEchocardiographyConcomitantMultivariate AnalysisCatheter Ablationcardiovascular systemCardiologyFemalepremature ventricular complexCardiology and Cardiovascular MedicinebusinessKardiologia Polska
researchProduct

Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major

2013

Transfusion and iron chelation treatment have significantly reduced morbidity and improved survival of patients with thalassemia major. However, cardiac disease continues to be the most common cause of death. We report the left-ventricular ejection fraction, determined by echocardiography, in one hundred sixtyeight patients with thalassemia major followed for at least 5 years who received continuous monotherapy with deferoxamine (N = 108) or deferiprone (N = 60). The statistical analysis, using the generalized estimating equations model, indicated that the group treated with deferiprone had a significantly better left-ventricular ejection fraction than did those treated with deferoxamine (c…

AdultMalemedicine.medical_specialtyIron OverloadHeart DiseasesPyridonesThalassemiaDeferoxamineIron Chelating AgentsVentricular Function Leftlaw.inventionYoung Adultchemistry.chemical_compoundRandomized controlled triallawInternal medicineHumansMedicineDeferiproneIn patientYoung adultMolecular BiologyThalassemia major Left ventricular ejection fraction (LVEF) Deferiprone Deferoxamine Echocardiography ChelationRetrospective StudiesEjection fractionbusiness.industrybeta-ThalassemiaStroke VolumeRetrospective cohort studyCell BiologyHematologymedicine.diseaseDeferoxamineTreatment OutcomechemistryCardiologyMolecular MedicineFemalebusinessDeferipronemedicine.drug
researchProduct

Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function

2007

Some reports have suggested that white-coat hypertension (WCH) is associated with some features of the metabolic syndrome (MetS). These metabolic disturbances, instead of WCH per se, may potentially explain the greater extent of end-organ damage sometimes observed in WCH subjects (WCHs) when compared to normotensive individuals (NTs). The aim of the present cross-sectional study was to compare left ventricular (LV) structure and function in three groups of subjects: WCHs with MetS, WCHs without MetS and NTs. A total of 145 WCHs, 35% of whom had MetS, were enrolled. As controls, 35 NTs were also studied. In all subjects, routine blood chemistry, echocardiographic examination and 24-h ambulat…

AdultMalemedicine.medical_specialtyLeft ventricular structureAmbulatory blood pressureCross-sectional studyWhite coat hypertensionDoppler echocardiographyVentricular Function LeftMetabolic syndrome white-coat hypertension left ventricular massInternal medicineInternal MedicinemedicineHumansAgedMetabolic Syndromemedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseEchocardiography DopplerDeceleration timeEndocrinologyCross-Sectional StudiesBlood chemistryHypertensionCardiologyFemaleHypertrophy Left VentricularMetabolic syndromebusiness
researchProduct

Effect of dual blockade of renin–angiotensin system on TGFβ1 and left ventricular structure and function in hypertensive patients

2007

The effects of 24 weeks losartan and ramipril treatment, both alone and in combination, on left ventricular mass (LVM), circulating transforming growth factor beta1 (TGFbeta1), procollagen type I (PIP) and III (PIIIP), have been evaluated in hypertensive (HT) patients. A total of 57 HT with stage 1 and 2 essential hypertension were included. After 4 weeks run in, a randomized double-blind, three arms, double dummy, independent trial was used. All HT patients were randomly allocated to three treatment arms consisting of losartan (50 mg/daily), ramipril (5 mg/ daily) and combined (losartan 50 mg/daily + ramipril 5 mg/daily) for 24 weeks. TGFbeta1, PIP and PIIIP, LVM, LVM/h(2.7) and other echo…

AdultMalemedicine.medical_specialtyLeft ventricular structureHeart VentriclesBlood PressureEnzyme-Linked Immunosorbent AssayAngiotensin II Receptor BlockersPeptide hormoneSeverity of Illness IndexDual blockadeCollagen Type ILosartanVentricular Function LeftRenin-Angiotensin SystemTransforming Growth Factor beta1Double-Blind MethodRamiprilInternal medicineRenin–angiotensin systemPrevalenceInternal MedicineHumansMedicineAntihypertensive AgentsUltrasonographyAnalysis of Variancebusiness.industryMiddle AgedAngiotensin IICollagen Type IIITreatment OutcomeEndocrinologyItalyHypertensionACE inhibitorDrug Therapy CombinationFemaleHypertrophy Left VentricularbusinessBiomarkersmedicine.drugJournal of Human Hypertension
researchProduct

[Central blood pressure and vascular damage].

2014

Abstract Background and objective The aim of this study was to assess the relationship between central blood pressure and vascular damage. Patients and methods This cross-sectional study involved 393 never treated hypertensive patients (166 women). Clinical blood pressure (BP), 24 h blood pressure (BP 24 h ) and central blood pressure (CBP) were measured. Vascular organ damage (VOD) was assessed by calculating the albumin/creatinine ratio (ACR), wave pulse pressure velocity and echocardiographic left ventricular mass index (LVMI). Results Patients with VOD had higher values of BP, BP 24 h , and CBP than patients without ACR. When comparing several systolic BP, systolic BP 24 h had a higher …

AdultMalemedicine.medical_specialtyLogistic regressionchemistry.chemical_compoundVascular StiffnessCentral blood pressureInternal medicinemedicineHumansVascular DiseasesAgedUltrasonographyAged 80 and overCreatininebusiness.industryAlbuminOdds ratioMiddle Agedmedicine.diseasePeripheralSurgeryBlood pressureCross-Sectional StudiesLogistic ModelschemistryHypertensionCardiologyFemaleHypertrophy Left VentricularMetabolic syndromebusinessMedicina clinica
researchProduct

Normal reference values of multilayer longitudinal strain according to age decades in a healthy population: A single-centre experience.

2017

Aims Recent advancements in echocardiographic technology allow to analyse myocardial strain in multiple layers. Little is known about the impact of age on layer-specific longitudinal strain in healthy subjects. The aim of this study was to analyse the influence of age on multilayer longitudinal strain and establish normal reference values of layer-specific strain according to age decades in a healthy population referring to our echo laboratory using 2D speckle-tracking echocardiography with layer-specific software. Methods and results Two-hundred sixty-six healthy, consecutive subjects (mean age = 39.2 ± 17.5 years, women/men = 137/129), free of cardiovascular risk factors, were enrolled. S…

AdultMalemedicine.medical_specialtyLongitudinal strain030204 cardiovascular system & hematologyVentricular Function LeftCohort Studies03 medical and health sciences0302 clinical medicineReference ValuesInternal medicineLinear regressionImage Interpretation Computer-AssistedmedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineProspective StudiesProspective cohort studyObserver VariationStrain (chemistry)business.industrysubendocardial strainConfoundingsubepicardial strainAge FactorsStroke VolumeGeneral MedicineMiddle AgedHealthy VolunteersageingAgeingEchocardiographyReference valuesCardiologyLinear ModelsFemaleCardiology and Cardiovascular Medicinebusinessglobal longitudinal strainglobal longitudinal strain subepicardial strain subendocardial strain echocardiography ageingCohort studyEuropean heart journal. Cardiovascular Imaging
researchProduct

3D echocardiographic reference ranges for normal left ventricular volumes and strain: results from the EACVI NORRE study

2017

International audience; Aim: To obtain the normal ranges for 3D echocardiography (3DE) measurement of left ventricular (LV) volumes, function, and strain from a large group of healthy volunteers. Methods and results: A total of 440 (mean age: 45 ± 13 years) out of the 734 healthy subjects enrolled at 22 collaborating institutions of the Normal Reference Ranges for Echocardiography (NORRE) study had good-quality 3DE data sets that have been analysed with a vendor-independent software package allowing homogeneous measurements regardless of the echocardiographic machine used to acquire the data sets. Upper limits of LV end-diastolic and end-systolic volumes were larger in men (97 and 42 mL/m2)…

AdultMalemedicine.medical_specialtyLongitudinal strainadult echocardiographydeformation imagingHeart VentriclesCardiac VolumeDiastoleEchocardiography Three-Dimensional030204 cardiovascular system & hematologyVentricular Function LeftHeart VentricleReference values03 medical and health sciencesYoung Adultleft ventricular function0302 clinical medicineInternal medicineHealthy volunteersthree-dimensional echocardiographyMedicineCircumferential strainHumansRadiology Nuclear Medicine and imagingReference Value030212 general & internal medicineSystoleAgedEjection fractionStrain (chemistry)business.industryGeneral MedicineMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREMiddle AgedHealthy VolunteerHealthy Volunteers3. Good healthRadiology Nuclear Medicine and imagingReference valuesCardiologyFemale[SDV.IB]Life Sciences [q-bio]/BioengineeringbusinessCardiology and Cardiovascular MedicineHuman
researchProduct